← Open Payments lookup

VANESSA GREEN: Open Payments

NPI 1023850930 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,022 in 32 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $158 · 2025 $1,022

Food & beverage: $752Education: $270
CompanyPaymentsAmount
Janssen Biotech, Inc.4$222
Daiichi Sankyo Inc.4$179
Incyte Corporation2$109
ABBVIE INC.3$67
GENZYME CORPORATION1$37
Novartis Pharmaceuticals Corporation1$34
E.R. Squibb & Sons, L.L.C.2$34
SpringWorks Therapeutics, Inc.1$29
ADC THERAPEUTICS AMERICA, INC.1$29
Takeda Pharmaceuticals U.S.A., Inc.1$28

Products named: Enhertu, RYBREVANT, ERLEADA, AYVAKIT, KISQALI, OPDIVO, EMRELIS, OGSIVEO.

Industry payments across CA — which companies pay providers there.